Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting [Yahoo! F...
Zevra Therapeutics, Inc. (ZVRA)
Company Research
Source: Yahoo! Finance
CELEBRATION, Fla., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced that Elizabeth Berry-Kravis, M.D., Ph.D., Professor of Pediatrics, Neurological Sciences, and Biochemistry at Rush University Medical Center in Chicago, is presenting data demonstrating the relevance of the swallow domain as part of the Niemann-Pick disease Type C Clinical Severity Scale (NPCCSS) at the 53rd Child Neurology Society Annual Meeting , which takes place Nov. 11-14 in San Diego. The poster presentation includes a reassessment of individual swallow domain scoring categories, rater scoring instructions, and evaluation of the score linearity based on a qualitative study in which an independent research organization interviewed 12 NPC and swallow experts. Findings showed that the descriptions of the NPCCSS swallow response categories can be clea
Show less
Read more
Impact Snapshot
Event Time:
ZVRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZVRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZVRA alerts
High impacting Zevra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ZVRA
News
- Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 [Yahoo! Finance]Yahoo! Finance
- Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024GlobeNewswire
- Zevra Therapeutics Announces Organizational ChangesGlobeNewswire
- Zevra Therapeutics to Participate at Upcoming Investor ConferencesGlobeNewswire
- Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type CGlobeNewswire
ZVRA
Earnings
- 11/12/24 - Miss
ZVRA
Sec Filings
- 12/6/24 - Form 8-K
- 11/22/24 - Form 8-K
- 11/14/24 - Form SCHEDULE
- ZVRA's page on the SEC website